SOCS3 blocks HIF-1α expression to inhibit proliferation and angiogenesis of human small cell lung cancer by downregulating activation of Akt, but not STAT3

Wan,Jun; Che,Yun; Kang,Ningning; Wu,Wei

doi:10.3892/mmr.2015.3368

SOCS3 blocks HIF-1α expression to inhibit proliferation and angiogenesis of human small cell lung cancer by downregulating activation of Akt, but not STAT3

Authors:
- Jun Wan
- Yun Che
- Ningning Kang
- Wei Wu
View Affiliations

Affiliations: Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China, Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China
Published online on: February 17, 2015 https://doi.org/10.3892/mmr.2015.3368
Pages: 83-92
Copyright: © Wan et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Suppressor of cytokine signaling 3 (SOCS3) is a major negative regulator of signal transducer and activator of transcription 3 (STAT3) during tumorigenesis. Previous studies have indicated that SOCS3 also regulates other signaling pathways, such as PI3K/Akt. However, little is known about the specific molecular mechanisms by which SOCS3 regulates the proliferation and angiogenesis of small cell lung cancer (SCLC) cells. The present study investigated the effect of SOCS3 upregulation on the expression of hypoxia‑inducible factor‑1α (HIF‑1α) and how this affects the proliferation and angiogenesis of SCLC cells. It was investigated whether this interaction is associated with STAT3 or the Akt signaling pathway. The results of the present study revealed that SOCS3 negatively regulates proliferation and angiogenesis of NCI‑H446 cells and that HIF‑1α is required in this process. The results also suggested a suppressive role of SOCS3 in Akt signaling, but not STAT3 signaling to block HIF‑1α expression and a previously unidentified regulatory mechanism for Akt function. In conclusion, the present study suggested that SOCS3 targets the Akt signaling pathway to inhibit HIF‑1α expression and affect the growth and angiogenesis of SCLC cells, and may therefore be considered as a potential novel therapeutic for the treatment of SCLC.

View Figures

View References

1	Wan J, Ma J, Mei J and Shan G: The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells. J Exp Clin Cancer Res. 28:1502009. View Article : Google Scholar : PubMed/NCBI
2	Wan J, Chai H, Yu Z, et al: HIF-1alpha effects on angiogenic potential in human small cell lung carcinoma. J Exp Clin Cancer Res. 30:772011. View Article : Google Scholar
3	Lee GW, Go SI, Cho YJ, et al: Hypoxia-inducible factor-1alpha and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study. J Thorac Oncol. 7:528–534. 2012. View Article : Google Scholar : PubMed/NCBI
4	Ioannou M, Papamichali R, Kouvaras E, et al: Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma. Lung. 187:321–329. 2009. View Article : Google Scholar : PubMed/NCBI
5	Zhang W, Zhang H and Xing L: Antisense oligonucleotide of hypoxia-inducible factor-1alpha suppresses growth and tumorigenicity of lung cancer cells A549. J Huazhong Univ Sci Technolog Med Sci. 26:448–450. 2006. View Article : Google Scholar : PubMed/NCBI
6	Lee JW, Bae SH, Jeong JW, Kim SH and Kim KW: Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med. 36:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
7	Kappler M, Taubert H, Schubert J, Vordermark D and Eckert AW: The real face of HIF1alpha in the tumor process. Cell Cycle. 11:3932–3936. 2012. View Article : Google Scholar : PubMed/NCBI
8	Park KW, Nozell SE and Benveniste EN: Protective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3. PLoS One. 7:e508742012. View Article : Google Scholar : PubMed/NCBI
9	Zhang S, Guo D, Jiang L, Zhang Q, Qiu X and Wang E: SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitro. BMC Cancer. 8:1502008. View Article : Google Scholar : PubMed/NCBI
10	Baltayiannis G, Baltayiannis N and Tsianos EV: Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver. J BUON. 13:263–265. 2008.PubMed/NCBI
11	Tokita T, Maesawa C, Kimura T, et al: Methylation status of the SOCS3 gene in human malignant melanomas. Int J Oncol. 30:689–694. 2007.PubMed/NCBI
12	Tischoff I, Hengge UR, Vieth M, et al: Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett’s adenocarcinoma. Gut. 56:1047–1053. 2007. View Article : Google Scholar : PubMed/NCBI
13	Yu ZB, Bai L, Qian P, et al: Restoration of SOCS3 suppresses human lung adenocarcinoma cell growth by downregulating activation of Erk1/2, Akt apart from STAT3. Cell Biol Int. 33:995–1001. 2009. View Article : Google Scholar : PubMed/NCBI
14	Tokunaga E, Oki E, Egashira A, et al: Deregulation of the Akt pathway in human cancer. Curr Cancer Drug Targets. 8:27–36. 2008. View Article : Google Scholar : PubMed/NCBI
15	Dillon RL, White DE and Muller WJ: The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene. 26:1338–1345. 2007. View Article : Google Scholar : PubMed/NCBI
16	Campbell IG, Russell SE, Choong DY, et al: Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 64:7678–7681. 2004. View Article : Google Scholar : PubMed/NCBI
17	Zhang T, Cui GB, Zhang J, et al: Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation. Oncol Rep. 24:1683–1689. 2010.PubMed/NCBI
18	Littlefield SL, Baird MC, Anagnostopoulou A and Raptis L: Synthesis, characterization and Stat3 inhibitory properties of the prototypical platinum(IV) anticancer drug, [PtCl3(NO2) (NH3)2] (CPA-7). Inorg Chem. 47:2798–2804. 2008. View Article : Google Scholar : PubMed/NCBI
19	Xu Q, Briggs J, Park S, et al: Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 24:5552–5560. 2005. View Article : Google Scholar : PubMed/NCBI
20	Weber A, Hengge UR, Bardenheuer W, et al: SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene. 24:6699–6708. 2005. View Article : Google Scholar : PubMed/NCBI
21	Liu Q, Li G, Li R, et al: IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol. 100:165–176. 2010. View Article : Google Scholar : PubMed/NCBI
22	Kumar K, Wigfield S, Gee HE, et al: Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse zenografts. J Mol Med (Berl). 91:749–758. 2013. View Article : Google Scholar
23	Kimbro KS and Simons JW: Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer. 13:739–749. 2006. View Article : Google Scholar : PubMed/NCBI
24	Fraga A, Ribeiro R and Medeiros R: Tumor hypoxia: the role of HIF. Actas Urol Esp. 33:941–951. 2009.In Spanish. View Article : Google Scholar : PubMed/NCBI
25	Shi YH and Fang WG: Hypoxia-inducible factor-1 in tumour angiogenesis. World J Gastroenterol. 10:1082–1087. 2004.PubMed/NCBI
26	Fan LF, Diao LM, Chen DJ, et al: Expression of HIF-1 alpha and its relationship to apoptosis and proliferation in lung cancer. Ai Zheng. 21:254–258. 2002.In Chinese. PubMed/NCBI
27	Zhang S, Wang W, Wang E and Qiu X: SOCS3 expression is inversely correlated with Pyk2 in non-small cell lung cancer and exogenous SOCS3 inhibits proliferation and invasion of A549 cells. Pathology. 44:434–440. 2012. View Article : Google Scholar : PubMed/NCBI
28	He B, You L, Uematsu K, et al: SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci USA. 100:14133–14138. 2003. View Article : Google Scholar : PubMed/NCBI
29	Shouda T, Hiraoka K, Komiya S, et al: Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells. Cancer Lett. 231:176–184. 2006. View Article : Google Scholar : PubMed/NCBI
30	Yokogami K: Hypoxia-induced decreases in SOCS3 increase STAT3 activation and upregulate VEGF gene expression. Brain Tumor Pathol. 30:135–143. 2013. View Article : Google Scholar
31	Shen A, Chen Y, Hong F, et al: Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3. Oncol Rep. 28:2125–2130. 2012.PubMed/NCBI
32	Francipane MG, Eterno V, Spina V, et al: Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy. Cancer Res. 69:6141–6148. 2009. View Article : Google Scholar : PubMed/NCBI
33	Yu H and Jove R: The STATs of cancer - new molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004. View Article : Google Scholar : PubMed/NCBI
34	Yamasaki M, Nomura T, Sato F and Mimata H: Chronic hypoxia induces androgen-independent and invasive behavior in LNCaP human prostate cancer cells. Urol Oncol. 31:1124–1131. 2013. View Article : Google Scholar
35	Yang CL, Liu YY, Ma YG, et al: Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One. 7:e379602012. View Article : Google Scholar : PubMed/NCBI